Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BALPHARMA Bal Pharma Limited Pharma · Small | BALAXI BALAXI PHARMACEUTICALS LIMITED Pharma · Small | MEDICAMEQ Medicamen Biotech Limited Pharma · Small | AMBALALSA Ambalal Sarabhai Enterprises Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 19 | 10 | 19 | 45 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | Distress Watch | OVERVALUED | OVERVALUED | Financial Turnaround |
| Piotroski | 6/9 | 3/9 | 5/9 | 7/9 |
| Valuation | 7/30 | 4/30 | 4/30 | 17/30 |
| Growth | 8/25 | 1/25 | 5/25 | 12/25 |
| Quality | 0/20 | 0/20 | 0/20 | 2/20 |
| Balance Sheet | 0/15 | 10/15 | 9/15 | 7/15 |
| Cash Flow | 9/10 | 1/10 | 0/10 | 5/10 |
| Price | ₹87.79 | ₹24.22 | ₹239.75 | ₹34.3 |
| P/E | 21.60 | 95.20 | 31.40 | 14.20 |
| P/B | 1.65 | 0.54 | 1.10 | 1.67 |
| ROE | 7.87% | 0.59% | 3.95% | 12.40% |
| ROCE | 9.69% | 3.11% | 5.43% | 11.50% |
| Debt / Equity | 1.95 | 0.23 | 0.17 | 0.36 |
| FCF Yield | 6.67% | — | — | 1.14% |
| Dividend Y | 1.41% | — | 0.45% | — |
| Altman Z | 1.71 | 3.06 | 3.86 | 2.77 |
| Promoter % | 50.87% | 65.99% | 40.46% | 31.36% |
| Mkt Cap (₹Cr) | 135.00 | 135.00 | 303.00 | 264.00 |
| Graham # | ₹67.63 | ₹16.24 | ₹180.21 | ₹32.87 |
| Fair PE | 16.1 | 0.9 | 5.8 | 42.3 |
| MoS % | -38.7% | -10731.4% | -483.4% | +65.1% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBALPHARMA71
BALAXI28
MEDICAMEQ47
AMBALALSA97